Press Release

Printer Friendly Version View printer-friendly version
<< Back
Sparton Corporation Reports Fiscal 2017 Third Quarter Results

SCHAUMBURG, Ill.--(BUSINESS WIRE)--May 9, 2017-- Sparton Corporation (NYSE:SPA) today announced results for the third quarter of fiscal year 2017 ended April 2, 2017.

Third Quarter Financial Results and Highlights

Joseph J. Hartnett, Interim President & CEO, commented, “Our Medical facilities are continuing to perform well while certain Mil/Aero and industrial facilities experienced unexpected delays in a couple of customer programs. As expected, our ECP Segment performance improved significantly over the prior quarter. Overall, while we are not satisfied with the quarter’s results, we are making progress in building a stronger more productive infrastructure while continuing to explore a potential acquisition of the Company.”

Joe McCormack, Senior Vice President and CFO, commented, “We are pleased that we were able to hold the line on our long-term debt during the quarter in light of investments in infrastructure and working capital needs in the quarter. The management of debt levels, generation of free cash flow and optimization of earnings continues to be a priority of the Company."

Consolidated:

• Net sales of $95.4 million

• Gross profit margin increased 140 bps from prior quarter to 17.7%

• SG&A expenses of $12.9 million or 13.5% of sales; adjusted SG&A of $12.2 million, 12.8% of sales

• Earnings per share of $0.04, adjusted Earnings per share of $0.22

• Adjusted EBITDA of $5.3 million, a 5.6% adjusted EBITDA margin

MDS Segment:

• Gross sales of $61.1 million

• Gross profit margin of 11.0%

• Operating loss of $0.7 million

• Adjusted EBITDA of $4.3 million, a 7.1% adjusted EBITDA margin

• New program wins in Q3 have expected revenue of $12.5 million when fully ramped up into production

• Trailing four quarter win revenue of $54.3 million, which continues to support our future organic growth

• Backlog of $118 million

ECP Segment:

• Gross sales of $37.1 million

• Gross profit margin of 27.6%

• Operating income of $5.3 million

• Adjusted EBITDA of $7.1 million, a 19.1% adjusted EBITDA margin

• Backlog of $124 million comprised principally of $105 million in domestic sonobuoys, $7 million in foreign sonobuoys, and $12 million in rugged electronics and other

         

SELECTED FINANCIAL DATA

 
For the Quarters Ended For First Three Quarters
Q3 FY17     Q2 FY17     Q3 FY16 2017     2016
(Dollars in thousands, except per share data)
Consolidated:
Net sales $ 95,410 $ 97,399 $ 102,175 $ 293,176 $ 312,395
Gross profit 16,915 15,898 19,067 50,098 58,726
Selling and administrative expenses 12,862 12,953 13,727 39,198 41,691
Operating income 1,530 221 2,676 3,083 7,628
Adjusted operating income (non-GAAP) 4,264 3,107 6,101 11,685 17,776
Earnings per share 0.04 (0.09 ) 0.12 (0.04 ) 0.38
Adjusted Earnings per share (non-GAAP) 0.22 0.10 0.34 0.53 1.00
EBITDA (non-GAAP) 5,135 3,890 6,546 14,096 19,569
Adjusted EBITDA (non-GAAP) 5,318 5,553 7,865 17,014 23,519
Adjusted EBITDA margin (non-GAAP) 5.6 % 5.7 % 7.7 % 5.8 % 7.5 %
Free cash flow (non-GAAP) $ (1,424 ) $ 10,008 $ 6,235 $ 10,677 $ 16,081
 
MDS Segment:
Gross sales $ 61,084 $ 67,382 $ 68,187 $ 193,468 $ 209,730
Intercompany sales (2,654 ) (2,333 ) (3,533 ) (7,187 ) (13,402 )
Net sales 58,430 65,049 64,654 186,281 196,328
Gross profit 6,690 8,357 7,771 22,341 25,056
Selling and administrative expenses 3,207 3,384 3,608 10,099 11,466
Allocation of corporate expenses 2,477 2,177 2,242 7,122 6,911
Operating Income (loss) (722 ) 986 231 (250 ) 48
Adjusted Segment EBITDA (non-GAAP) $ 4,343 $ 5,875 $ 5,237 $ 14,909 $ 16,831
 
ECP Segment:
Gross sales $ 37,053 $ 32,350 $ 37,566 $ 106,995 $ 116,297
Intercompany sales (73 )   (45 ) (100 ) (230 )
Net sales 36,980 32,350 37,521 106,895 116,067
Gross profit 10,225 7,541 11,296 27,757 33,670
Selling and administrative expenses 2,922 2,550 2,837 8,096 8,045
Allocation of corporate expenses 1,238 995 1,061 3,433 3,165
Operating Income 5,270 3,082 6,424 13,781 19,684
Adjusted Segment EBITDA (non-GAAP) $ 7,072 $ 4,646 $ 8,141 $ 18,946 $ 24,813
 

Liquidity and Capital Resources

As of April 2, 2017, the Company had $82 million available under its $175 million credit facility.

Outlook

Mr. Hartnett concluded, “We expect revenues for the fourth quarter of fiscal 2017 of between $97 and $101 million and gross margins are expected to come in at approximately 18%.”

Potential Sale Transaction

As previously announced, the Board of Directors of Sparton Corporation is exploring a possible sale of the Company. There can be no assurance that such a sale will occur.

Conference Call

The Company will host a conference call on Wednesday, May 10, 2017 at 10:00 a.m. CDT/11:00 a.m. EDT to discuss its fiscal year 2017 third quarter financial results. To participate, callers should dial 800-706-4417. Participants should dial in at least 5 minutes prior to the start of the call. A web presentation link, including the slide presentation which will accompany the call, will also be available for the conference call: http://tinyurl.com/kskr358. The presentation and conference call audio will be available on Sparton’s website: http://www.sparton.com in the “Investors” section.

Non-GAAP Financial Measures

In addition to reporting financial results in accordance with U.S. generally accepted accounting principles (“GAAP”), Sparton Corporation has provided certain non-GAAP financial measures as additional information for its operating results. These measures have not been prepared in accordance with GAAP and may be different from measures used by other companies. Whenever we use non-GAAP financial measures, we designate these measures, which exclude the effects of certain expenses and income, as “adjusted” and provide a reconciliation of non-GAAP financial measures to the most closely applicable GAAP financial measure. The non-GAAP financial measures eliminate or add certain items of expense and income from total operating expense and income taxes. Management believes that this presentation is helpful to investors in evaluating the current operational and financial performance of our business and facilitates comparisons to historical results of operations. Management discloses this information along with a reconciliation of the comparable GAAP amounts to provide access to the detail and nature of adjustments made to GAAP financial results. While some of these excluded items have been periodically reported in our statements of operations, their occurrence in future periods depends on future business and economic factors, among other evaluation criteria, and the occurrence of such events and factors may frequently be beyond the control of management.

When we calculate adjusted earnings per share, adjusted EBITDA and other adjustments to the statements of income, we exclude certain expenses and income because we believe that they are not related directly to the underlying performance of our fundamental business operations. We exclude these measures when reviewing financial results and for business planning. Although these events are reflected in our GAAP financial statements, these transactions may limit the comparability of our fundamental operations with prior and future periods. We believe EBITDA and adjusted EBITDA are commonly used by financial analysts and others in the industries in which the Company operates and, thus, provides useful information to investors. The Company does not intend, nor should the reader consider, EBITDA or adjusted EBITDA to be an alternative to operating income, net income, net cash provided by operating activities or any other items calculated in accordance with GAAP. The Company's definition of adjusted EBITDA may not be comparable with other companies. Accordingly, the measurement has limitations depending on its use.

About Sparton Corporation

Sparton Corporation (NYSE:SPA), now in its 117th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service and refurbishment. The primary markets served are Medical & Biotechnology, Military & Aerospace and Industrial & Commercial. Headquartered in Schaumburg, IL, Sparton currently has thirteen manufacturing locations and engineering design centers worldwide. Sparton's Web site may be accessed at www.sparton.com.

Safe Harbor and Fair Disclosure Statement

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting future results, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in Sparton’s filings with the Securities and Exchange Commission (SEC). The matters discussed in this press release may also involve risks and uncertainties concerning Sparton’s services described in Sparton’s filings with the SEC. In particular, see the risk factors described in Sparton’s most recent Form 10-K and Form 10-Q. Sparton assumes no obligation to update the forward-looking information contained in this press release.

                 

CONSOLIDATING FINANCIAL INFORMATION - Q3 FISCAL YEAR 2017

(Dollars in thousands, except per share data)

 
Corporate MDS ECP Total
Net Sales $ $ 58,430 $ 36,980 $ 95,410
Cost of goods sold   51,740   26,755   78,495  
Gross profit 6,690 10,225 $ 16,915
Operating expenses:
Selling and administrative 6,733 3,207 2,922 12,862
Selling and administrative - Corp allocations (3,715 ) 2,477 1,238
Internal research and development 424 424
Amortization of intangible assets   1,728   371   2,099  
Total operating expenses 3,018   7,412   4,955   15,385  
Income (loss) from operations (3,018 ) (722 ) 5,270 1,530
Interest expense, net (1,082 ) 7 (1,075 )
Other income (expense) 8 11 1 20
Income taxes (4 ) (42 )   (46 )
Net income (loss) $ (4,096 ) $ (746 ) $ 5,271   $ 429  
Income per share of common stock:
Basic $ 0.04
Diluted 0.04
Weighted average shares of common stock outstanding:
Basic 9,818,789
Diluted 9,818,789
 
                 

CONSOLIDATING FINANCIAL INFORMATION - Q3 FISCAL YEAR 2016

(Dollars in thousands, except per share data)

 
Corporate MDS ECP Total
Net Sales $ $ 64,654 $ 37,521 $ 102,175
Cost of goods sold   56,883   26,225   83,108  
Gross profit 7,771 11,296 $ 19,067
Operating expenses:
Selling and administrative 7,282 3,608 2,837 13,727
Selling and administrative - Corp allocations (3,303 ) 2,242 1,061
Internal research and development 561 561
Amortization of intangible assets 1,948 413 2,361
Restructuring charges   (258 )   (258 )
Total operating expenses 3,979   7,540   4,872   16,391  
Income (loss) from operations (3,979 ) 231 6,424 2,676
Interest expense, net (957 ) 1 (956 )
Other income (expense) 8 (5 ) 25 28
Income taxes (612 )     (612 )
Net income (loss) $ (5,540 ) $ 227   $ 6,449   $ 1,136  
Income per share of common stock:
Basic $ 0.12
Diluted 0.12
Weighted average shares of common stock outstanding:
Basic 9,789,807
Diluted 9,789,807
 
     

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

 
For the First Three Quarters
2017     2016
($ in thousands)
Cash Flows from Operating Activities:
Operating activities, net of working capital changes $ 11,830 $ 14,234
Net changes in working capital 3,676   7,074  
Cash Flows from Operating Activities 15,506 21,308
Cash Flows from Investing Activities:
Business acquisitions 750
Capital expenditures (4,829 ) (5,227 )
Other investing activities 17   221  
Cash Flows from Investing Activities (4,812 ) (4,256 )
Cash Flows from Financing Activities:
Net change in credit facility (9,584 ) (31,100 )
Other financing activities (210 ) (32 )
Cash Flows from Financing Activities (9,794 ) (31,132 )
Change in Cash and Cash Equivalents 900 (14,080 )
 
Cash and Cash Equivalents - Beginning 132   14,914  
Cash and Cash Equivalents - Ending $ 1,032   $ 834  
 
         

CONDENSED CONSOLIDATED BALANCE SHEETS

 
April 2,
2017
July 3,
2016
($ in thousands)
Assets
Cash and cash equivalents $ 1,032 $ 132
Accounts receivable, net 48,092 46,759
Inventories 64,966 77,871
Prepaid and other current assets 4,933 5,844
Property, plant and equipment, net 33,819 33,320
Goodwill 12,663 12,663
Other intangible assets, net 30,434 36,933
Other assets 31,546   32,476
Total assets $ 227,485   $ 245,998
Liabilities and Shareholders’ Equity
Accounts payable $ 35,366 $ 38,290
Accrued expenses 18,253 24,149
Credit facility 87,622 97,206
Capital lease obligations, long term 234 332
Environmental 5,614 6,117
Pension 1,168 1,276
Shareholders’ Equity 79,228   78,628
Total Liabilities and Shareholders’ Equity $ 227,485   $ 245,998
 

RECONCILIATION OF NON-GAAP MEASURES

                 

EBITDA Reconciliation (Non-GAAP) - Q3 Fiscal Year 2017

(Dollars in thousands)

 
Corporate MDS ECP Total
Net income (loss) $ (4,096 ) $ (746 ) $ 5,271 $ 429
Interest expense, net 1,082 (7 ) 1,075
Income taxes 4 42 46
Amortization of intangible assets 1,728 371 2,099
Depreciation included in SG&A above 445 849 192 1,486
Selling and administrative - Corp allocations (3,715 ) 2,477   1,238    
EBITDA, excluding corporate allocation (6,280 ) 4,343 7,072 5,135
Adjustments for nonrecurring operating expenses:
Stock-based compensation (452 ) (452 )
Costs related to potential sale of Company 635       635  
Adjusted EBITDA, before corporate allocation $ (6,097 ) $ 4,343   $ 7,072   $ 5,318  
 
Adjusted EBITDA, after corporate allocation $ (2,382 ) $ 1,866 $ 5,834 $ 5,318
 
Adjusted EBITDA margin 5.6 %
 
                 

EBITDA Reconciliation (Non-GAAP) - Q3 Fiscal Year 2016

(Dollars in thousands)

 
Corporate MDS ECP Total
Net income (loss) $ (5,540 ) $ 227 $ 6,449 $ 1,136
Interest expense, net 957 (1 ) 956
Income taxes 612 612
Amortization of intangible assets 1,948 413 2,361
Depreciation included in SG&A above 384 879 218 1,481
Selling and administrative - Corp allocations (3,303 ) 2,242   1,061    
EBITDA, excluding corporate allocation (6,890 ) 5,295 8,141 6,546
Adjustments for nonrecurring operating expenses:
Stock-based compensation 255 255
Costs related to potential sale of company 430 430
Restructuring charges 371 (258 ) 113
Other non-recurring costs 321   200     521  
Adjusted EBITDA, before corporate allocation $ (5,513 ) $ 5,237   $ 8,141   $ 7,865  
 
Adjusted EBITDA, after corporate allocation $ (2,210 ) $ 2,995 $ 7,080 $ 7,865
 
Adjusted EBITDA margin 7.7 %
 
     

Adjusted SG&A and Operating Income (Non-GAAP)

 
For the Quarters Ended
Q3 FY17   Q2 FY17   Q3 FY16
SG&A  

Operating
Income

SG&A  

Operating
Income

SG&A  

Operating
Income

(Dollars in thousands)
As reported $ 12,862 $ 1,530 $ 12,953 $ 221 $ 13,727 $ 2,676
Percentage of sales 13.5 % 1.6 % 13.3 % 0.2 % 13.4 % 2.6 %
Adjustments:
Amortization of intangible assets 2,099 2,191 2,361
Costs related to potential sale of Company 635 635 695 695 430 430
Restructuring costs 371 113
Other nonrecurring adjustments         321   521  
Total adjustments 635   2,734   695   2,886   1,122   3,425  
As adjusted $ 12,227   $ 4,264   $ 12,258   $ 3,107   $ 12,605   $ 6,101  
 
Adjusted percentage of sales 12.8 % 4.5 % 12.6 % 3.2 % 12.3 % 6.0 %
    For the First Three Quarters
2017     2016
SG&A    

Operating
Income

SG&A    

Operating
Income

(Dollars in thousands)
As reported $ 39,198 $ 3,083 $ 41,691 $ 7,628
Percentage of sales 13.4 % 1.0 % 13.4 % 2.4 %
Adjustments:
Amortization of intangible assets 6,509 7,323
Costs related to potential sale of Company 1,993 1,993 430 430
Restructuring costs 371 2,473
Reversal of accrued contingent consideration (1,530 )
Other nonrecurring adjustments 100   100   1,252   1,452  
Total adjustments 2,093   8,602   2,053   10,148  
As adjusted $ 37,105   $ 11,685   $ 39,638   $ 17,776  
 
Adjusted percentage of sales 12.7 % 4.0 % 12.7 % 5.7 %
 
         

Adjusted EPS (Non-GAAP)

 
For the Quarters Ended For the First Three Quarters
Q3 FY17     Q2 FY17     Q3 FY16 2017     2016
(Dollars in thousands, except per share data)
Earnings per share - diluted, as reported $ 0.04 $ (0.09 ) $ 0.12 $ (0.04 ) $ 0.38
Nonrecurring items 0.04 0.05 0.06 0.14 0.13
Amortization of intangible assets 0.14   0.14   0.16   0.43   0.49  
Adjusted earnings per share $ 0.22   $ 0.10   $ 0.34   $ 0.53   $ 1.00  
 
Adjustments, net of tax:
Costs related to potential sale of Company $ 413 $ 452 $ 280 $ 1,295 $ 280
Restructuring costs 73 1,607
Reversal of accrued contingent consideration (1,530 )
Other nonrecurring adjustments     339   65   944  
Total nonrecurring 413 452 692 1,360 1,301
Amortization of intangible assets 1,364   1,424   1,535   4,231   4,760  
Total adjustments $ 1,777   $ 1,876   $ 2,227   $ 5,591   $ 6,061  

Source: Sparton Corporation

Sparton Corporation
Joe McCormack, 847-762-5800
ir@sparton.com





Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.